{{Rsnum
|rsid=1823068
|Gene=PDE4D
|Chromosome=5
|position=59380223
|Orientation=plus
|GMAF=0.1873
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PDE4D
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 65.5 | 29.2 | 5.3
| HCB | 57.4 | 37.5 | 5.1
| JPT | 58.9 | 35.7 | 5.4
| YRI | 64.6 | 31.3 | 4.1
| ASW | 78.9 | 17.5 | 3.5
| CHB | 57.4 | 37.5 | 5.1
| CHD | 60.2 | 33.3 | 6.5
| GIH | 76.2 | 22.8 | 1.0
| LWK | 51.4 | 42.2 | 6.4
| MEX | 82.5 | 17.5 | 0.0
| MKK | 37.2 | 52.6 | 10.3
| TSI | 73.5 | 22.5 | 3.9
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs1823068
|PubMedID=17903308
|Condition=Sleepiness
|Gene=PDE4D
|Risk Allele=
|pValue=3.00E-008
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1823068
|Name_s=
|Gene_s=PDE4D
|Feature=
|Evidence=PubMed ID:17903308; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association of sleep and circadian phenotypes (Initial Sample Size: 738 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Sleepiness.
|Drugs=
|Drug Classes=
|Diseases=Sleep Disorders
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356474
}}

{{PMID Auto
|PMID=17903291
|Title=The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1823068
|overall_frequency_n=26
|overall_frequency_d=118
|overall_frequency=0.220339
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=21
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}